Compare CVRX & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVRX | CYCU |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.3M | 94.8M |
| IPO Year | 2021 | 2021 |
| Metric | CVRX | CYCU |
|---|---|---|
| Price | $1.53 | $2.69 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.58 | N/A |
| AVG Volume (30 Days) | ★ 474.0K | 165.4K |
| Earning Date | 11-04-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $56,651,000.00 | $17,771,485.00 |
| Revenue This Year | $3.89 | $13.37 |
| Revenue Next Year | $12.45 | $66.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 10.45 | N/A |
| 52 Week Low | $2.20 | $0.16 |
| 52 Week High | $11.30 | $7.13 |
| Indicator | CVRX | CYCU |
|---|---|---|
| Relative Strength Index (RSI) | 23.88 | 51.90 |
| Support Level | N/A | $2.56 |
| Resistance Level | $3.26 | $3.00 |
| Average True Range (ATR) | 0.24 | 0.24 |
| MACD | -0.08 | -0.16 |
| Stochastic Oscillator | 2.84 | 15.79 |
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).